Align Technology, US0162551016

Align Technology stock holds near $159 after Q2 beat

Published on 08/28/2026 at 12:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Align Technology stock drew attention after Q2 revenue of $1.06 billion and EPS of $2.64 topped estimates, while the shares opened at $158.84 with a $11.38 billion market value.

Börsenhändler im NASDAQ-Saal mit Medtech-Kurscharts auf Bildschirmen
Align Technology Inc. Börsen-Editorial NASDAQ Handelssaal mit steigenden Medtech-Aktienkursen und Händlern US0162551016, Illustration mit AI erstellt.

Align Technology (US0162551016) is trading with a clear earnings backdrop after its latest quarter delivered $1.06 billion in revenue and $2.64 in earnings per share, both ahead of estimates, while the stock opened at $158.84 and carried a $11.38 billion market capitalization.

The most recent update also showed a 52-week range of $122.00 to $200.43, a 200-day moving average of $175.27, and a consensus price target of $206.36, which leaves the shares below both the long-term trend line and the average target.

Earnings set the tone

According to the latest reported quarter, revenue rose 4.3% year over year to $1.06 billion, and EPS improved to $2.64 from $2.49 a year earlier. Net margin was 9.99%, and return on equity reached 15.86%, a combination that points to a business still producing solid profitability.

Guidance is the next anchor: the latest outlook calls for full-year EPS of 9.38, which gives investors a current benchmark for the rest of 2026. The same update also showed analysts rating the stock at Moderate Buy, with eight Buy ratings, six Hold ratings, and one Strong Buy.

Chart and valuation

The shares opened at $158.84, which sits more than 20 percent below the 52-week high of $200.43 and above the 52-week low of $122.00. That gap matters because it leaves the stock in the middle of its annual range rather than at the top of it.

Valuation is not cheap on the reported numbers either, with a P/E ratio of 27.62 and a P/E/G ratio of 1.69. The market cap of $11.38 billion gives the stock enough size to stay on institutional screens, but the 200-day average at $175.27 shows that the long trend still points higher than the current open.

Invisalign remains central

Align Technology still leans on Invisalign, its clear-aligner system that uses 3D imaging and CAD-based customization to reposition teeth. That product remains the core commercial engine behind the company's earnings mix and its broader digital dentistry platform.

Stock level

As of August 28, 2026, Align Technology stock was trading at $158.84.

Fact box

Company: Align Technology, Inc.

ISIN: US0162551016

Ticker: ALGN

Exchange: Nasdaq

Price (as of August 28, 2026): $158.84 USD

Market cap: $11.38 billion

Sector / Industry: Health Care / Medical Devices

Index membership: Nasdaq-100

Read more

More on Align Technology stock

Disclaimer...

en | US0162551016 | ALIGN TECHNOLOGY | boerse | 70013998 | bgmi